Definium Therapeutics develops treatments based on psychedelic compounds for brain health disorders such as anxiety, depression and autism. It last closed at $28.34 on Nov 20, down 3.87% on the day. The next earnings report for DFTX is expected around Mon, Jan 11, 2027. For the quarter ended Sep 2026, DFTX reported EPS of -$0.46. Over its last 8 reports the stock moved an average of 2.6% the session after earnings. Over the last 12 months DFTX insiders bought $0 of stock on the open market and sold $7.0M, according to SEC Form 4 filings.
AI Auto Pilots
Is DFTX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold DFTX.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on DFTXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
DFTX · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend, nearing oversold
The stock is 17% below its 20 day and 24% below its 50 day average. It is 8% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 34), near oversold. The nearest support is the Pivot S1 at $27.84, and the nearest resistance the Pivot at $28.67.
Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityNormal, 6.9%/day
Key levels
$49.7052 week high+75.4%
$39.15100 day average+38.1%
$35.97Swing high (Nov 10)+26.9%
$35.1850 day average+24.1%
$33.1720 day average+17.0%
$30.73200 day average+8.4%
$29.17Pivot R1+2.9%
$28.67Pivot+1.2%
$28.34Last close
$27.84Pivot S1−1.8%
$22.15Swing low (Jun 2)−21.8%
$10.4652 week low−63.1%
Indicators
RSI (14)
33.72
Weak, oversold below 30
Neutral
MACD
-1.77
Below its signal line
Bearish
Stochastic
8.6
Near the bottom of its range
Oversold
ADX (14)
21.3
Weak trend
Williams %R
-97.9
Oversold below −80, overbought above −20
Oversold
CCI (20)
-128.9
Oversold below −100, overbought above 100
Oversold
Rate of change
−14.8%
Change over 10 sessions
Bearish
ATR (14)
$1.96
Typical daily range, 6.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Pullback inside a longer uptrend, nearing oversold
Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityNormal, 16.6%/day
Key levels
$49.7052 week high+75.4%
$39.15100 day average+38.1%
$35.97Swing high (Nov 10)+26.9%
$35.1850 day average+24.1%
$33.1720 day average+17.0%
$30.73200 day average+8.4%
$29.17Pivot R1+2.9%
$28.67Pivot+1.2%
$28.34Last close
$27.84Pivot S1−1.8%
$22.15Swing low (Jun 2)−21.8%
$10.4652 week low−63.1%
Indicators
RSI (14)
40.85
Middle of its range
Neutral
MACD
0.74
Below its signal line
Bearish
Stochastic
9.2
Near the bottom of its range
Oversold
ADX (14)
40.1
Strong downtrend
Williams %R
-99.1
Oversold below −80, overbought above −20
Oversold
CCI (20)
-153.0
Oversold below −100, overbought above 100
Oversold
Rate of change
−27.1%
Change over 10 sessions
Bearish
ATR (14)
$4.72
Typical daily range, 16.6% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for DFTX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how DFTX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow DFTX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for DFTXHow many large options trades hit DFTX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in DFTX in the last 90 days.
From SEC Form 4 filings by DFTX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether DFTX is in one of them and how their past DFTX trades turned out.
Definium Therapeutics is a drug developer based in New York that is working on treatments for brain health conditions. Its main product candidates are derived from psychedelic and empathogen compounds. The lead candidate, DT120, is being tested in adults with generalized anxiety disorder and major depressive disorder, and a second candidate, DT402, is being studied in adults with autism spectrum disorder. None of its products are approved for sale yet, and the company is aiming to offer them to patients under medical care.